Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspectiveJeremy Yuen‐Chun Teoh, Marek Babjuk, Ashish M. Kamat et al.|Nature Reviews Urology|2022Cited by 196
Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global AnalysisJunjie Huang, Martin C. S. Wong, Sze Chai Chan et al.|European Urology Oncology|2022Cited by 88
The Impact of Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma: A Comprehensive Systematic Review and Meta-AnalysisŁukasz Nowak, Tomasz Szydełko, Wojciech Krajewski et al.|Journal of Clinical Medicine|2021Cited by 46
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group CollaborationFrancesco Soria, Paolo Gontero, Matteo Rosazza et al.|European Urology Oncology|2024Cited by 32
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancerWojciech Krajewski, Ekaterina Laukhtina, Júlia Aumatell et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 29